Literature DB >> 33446833

Whole-exome sequencing identifies susceptibility genes and pathways for idiopathic pulmonary fibrosis in the Chinese population.

Chuling Fang1, Hui Huang1, Yujia Feng2, Qian Zhang1, Na Wang1, Xiaoyan Jing1, Jian Guo1, Martin Ferianc3, Zuojun Xu4.   

Abstract

Genetic factors play a role in the risk of idiopathic pulmonary fibrosis (IPF). Specifically, MUC5B rs35705950 non-risk alleles and immunologic aberrations were associated with the IPF's progression. However, rare genetic variants have not been systematically investigated in Chinese IPF patients. In this study, we aimed to improve understanding of the genetic architecture of IPF in the Chinese population and to assess whether rare protein-coding variants in the immunity pathway genes are enriched in the IPF patients with non-risk alleles at rs35705950. A case-control exome-wide study including 110 IPF patients and 60 matched healthy controls was conducted. rs35705950 was genotyped by Sanger sequencing. To identify genes enriched in IPF, gene-based association analyses were performed. Identified genes were included for further pathway analyses using gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). Associations between rs35705950 and genes enriched in the immunity pathway were also tested. 226 genes that were enriched with deleterious variants were identified in IPF patients. Out of them, 36 genes were significantly enriched in GO and KEGG pathways in the IPF. Pathway analyses implicated that these genes were involved in the immune response and cell adhesion. Rare protein-altering variants in genes related to the immunity pathway did not significantly differ between patients with a MUC5B risk allele and individuals without risk allele. We drafted a comprehensive mutational landscape of rare protein-coding variants in the Chinese IPF and identified genes related to immune response and cell adhesion. These results partially explain changes in gene expression involved in the immunity/inflammatory pathways in IPF patients.

Entities:  

Year:  2021        PMID: 33446833      PMCID: PMC7809470          DOI: 10.1038/s41598-020-80944-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  59 in total

1.  A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis.

Authors:  T Mushiroda; S Wattanapokayakit; A Takahashi; T Nukiwa; S Kudoh; T Ogura; H Taniguchi; M Kubo; N Kamatani; Y Nakamura
Journal:  J Med Genet       Date:  2008-10       Impact factor: 6.318

2.  A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis.

Authors:  Yingze Zhang; Imre Noth; Joe G N Garcia; Naftali Kaminski
Journal:  N Engl J Med       Date:  2011-04-21       Impact factor: 91.245

3.  TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis.

Authors:  Glenda Trujillo; Alessia Meneghin; Kevin R Flaherty; Lynette M Sholl; Jeffrey L Myers; Ella A Kazerooni; Barry H Gross; Sameer R Oak; Ana Lucia Coelho; Holly Evanoff; Elizabeth Day; Galen B Toews; Amrita D Joshi; Matthew A Schaller; Beatrice Waters; Gabor Jarai; John Westwick; Steven L Kunkel; Fernando J Martinez; Cory M Hogaboam
Journal:  Sci Transl Med       Date:  2010-11-10       Impact factor: 17.956

4.  Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003.

Authors:  Amy L Olson; Jeffrey J Swigris; Dennis C Lezotte; Jill M Norris; Carla G Wilson; Kevin K Brown
Journal:  Am J Respir Crit Care Med       Date:  2007-05-03       Impact factor: 21.405

5.  Analysis of an IL-10 polymorphism in idiopathic pulmonary fibrosis.

Authors:  H A Whittington; R W Freeburn; S I H Godinho; J Egan; Y Haider; A B Millar
Journal:  Genes Immun       Date:  2003-06       Impact factor: 2.676

6.  MICA polymorphisms and decreased expression of the MICA receptor NKG2D contribute to idiopathic pulmonary fibrosis susceptibility.

Authors:  Arnoldo Aquino-Galvez; Martha Pérez-Rodríguez; Angel Camarena; Ramces Falfan-Valencia; Víctor Ruiz; Martha Montaño; Lourdes Barrera; Isabel Sada-Ovalle; Remedios Ramírez; Julio Granados; Annie Pardo; Moisés Selman
Journal:  Hum Genet       Date:  2009-04-12       Impact factor: 4.132

Review 7.  Drug Treatment of Idiopathic Pulmonary Fibrosis: Systematic Review and Network Meta-Analysis.

Authors:  William J Canestaro; Sara H Forrester; Ganesh Raghu; Lawrence Ho; Beth E Devine
Journal:  Chest       Date:  2016-01-13       Impact factor: 9.410

8.  The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis.

Authors:  David N O'Dwyer; Michelle E Armstrong; Glenda Trujillo; Gordon Cooke; Michael P Keane; Padraic G Fallon; A John Simpson; Ann B Millar; Emmet E McGrath; Moira K Whyte; Nik Hirani; Cory M Hogaboam; Seamas C Donnelly
Journal:  Am J Respir Crit Care Med       Date:  2013-12-15       Impact factor: 21.405

9.  Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.

Authors:  Richard J Allen; Joanne Porte; Rebecca Braybrooke; Carlos Flores; Tasha E Fingerlin; Justin M Oldham; Beatriz Guillen-Guio; Shwu-Fan Ma; Tsukasa Okamoto; Alison E John; Ma'en Obeidat; Ivana V Yang; Amanda Henry; Richard B Hubbard; Vidya Navaratnam; Gauri Saini; Norma Thompson; Helen L Booth; Simon P Hart; Mike R Hill; Nik Hirani; Toby M Maher; Robin J McAnulty; Ann B Millar; Philip L Molyneaux; Helen Parfrey; Doris M Rassl; Moira K B Whyte; William A Fahy; Richard P Marshall; Eunice Oballa; Yohan Bossé; David C Nickle; Don D Sin; Wim Timens; Nick Shrine; Ian Sayers; Ian P Hall; Imre Noth; David A Schwartz; Martin D Tobin; Louise V Wain; R Gisli Jenkins
Journal:  Lancet Respir Med       Date:  2017-10-20       Impact factor: 102.642

10.  Inflammatory pathways are upregulated in the nasal epithelium in patients with idiopathic pulmonary fibrosis.

Authors:  Marc A Sala; Yalbi Itzel Balderas-Martínez; Ivette Buendía-Roldan; Hiam Abdala-Valencia; Kiwon Nam; Manu Jain; Sangeeta Bhorade; Ankit Bharat; Paul A Reyfman; Karen M Ridge; Annie Pardo; Jacob I Sznajder; G R Scott Budinger; Alexander V Misharin; Moises Selman
Journal:  Respir Res       Date:  2018-11-26
View more
  1 in total

1.  System-wide transcriptome damage and tissue identity loss in COVID-19 patients.

Authors:  Jiwoon Park; Jonathan Foox; Tyler Hether; David C Danko; Sarah Warren; Youngmi Kim; Jason Reeves; Daniel J Butler; Christopher Mozsary; Joel Rosiene; Alon Shaiber; Evan E Afshin; Matthew MacKay; André F Rendeiro; Yaron Bram; Vasuretha Chandar; Heather Geiger; Arryn Craney; Priya Velu; Ari M Melnick; Iman Hajirasouliha; Afshin Beheshti; Deanne Taylor; Amanda Saravia-Butler; Urminder Singh; Eve Syrkin Wurtele; Jonathan Schisler; Samantha Fennessey; André Corvelo; Michael C Zody; Soren Germer; Steven Salvatore; Shawn Levy; Shixiu Wu; Nicholas P Tatonetti; Sagi Shapira; Mirella Salvatore; Lars F Westblade; Melissa Cushing; Hanna Rennert; Alison J Kriegel; Olivier Elemento; Marcin Imielinski; Charles M Rice; Alain C Borczuk; Cem Meydan; Robert E Schwartz; Christopher E Mason
Journal:  Cell Rep Med       Date:  2022-01-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.